NYSE:RMD
ResMed Inc Stock News
$218.57
-1.40 (-0.636%)
At Close: May 17, 2024
Why Is ResMed (RMD) Down 1.7% Since Last Earnings Report?
12:35pm, Friday, 23'rd Feb 2024
ResMed (RMD) reported earnings 30 days ago. What's next for the stock?
Got $1,000? Buy These Hot Growth Stocks Before They Take Off
09:53am, Thursday, 22'nd Feb 2024
ResMed makes medical devices for sleep apnea and COPD, a potential market of over a billion people. DexCom is a market leader in continuous glucose monitoring devices for diabetes patients.
Here's Why Investors Should Retain ResMed (RMD) Stock for Now
02:36pm, Tuesday, 20'th Feb 2024
Investors are optimistic about ResMed's (RMD) increased adoption of AirSense10 and AirSense11 devices.
ResMed (RMD) to Treat Sleep Apnea With New AirCurve 11 (Revised)
11:30am, Friday, 16'th Feb 2024
ResMed's (RMD) new AirCurve11 series incorporates MyAir and AirView digital health apps to provide maximum comfort and support during therapy.
ResMed (RMD) to Treat Sleep Apnea With New AirCurve 11 Device
11:26am, Tuesday, 13'th Feb 2024
ResMed's (RMD) new AirCurve11 series incorporates myAir and AirView digital health apps to provide maximum comfort and support during therapy.
Why ResMed (RMD) is a Top Growth Stock for the Long-Term
10:46am, Monday, 05'th Feb 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
MoneyShow's Best Investment Ideas For 2024: Part 7
09:30am, Friday, 02'nd Feb 2024
MoneyShow presents top investment ideas for 2024 from their contributors. This year's edition presents a broad mix of conservative income stocks, more speculative but potentially more rewarding growth
Three-Stock Lunch: SoFi, Warner Bros. Discovery and ResMed
03:43pm, Monday, 29'th Jan 2024
Boris Schlossberg, BK Asset Management, joins 'Power Lunch' to discuss SoFi, Warner Bros. Discovery and ResMed.
Here's Why ResMed (RMD) is a Strong Momentum Stock
10:51am, Friday, 26'th Jan 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
ResMed (RMD) Q2 Earnings Beat Estimates, Margins Expand
01:06pm, Thursday, 25'th Jan 2024
ResMed's (RMD) Q2 results reflect cost discipline to support an acceleration in profitability.
Why ResMed Stock Is Jumping Today
12:07pm, Thursday, 25'th Jan 2024
ResMed topped consensus Wall Street revenue and earnings estimates with its fiscal Q2 results. The company delivered double-digit-percentage growth across all of its products and services.
ResMed Inc. (RMD) Q2 2024 Earnings Call Transcript
10:56pm, Wednesday, 24'th Jan 2024
ResMed Inc. (RMD) Q2 2024 Earnings Call Transcript
ResMed (RMD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
08:06pm, Wednesday, 24'th Jan 2024
While the top- and bottom-line numbers for ResMed (RMD) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare
ResMed (RMD) Tops Q2 Earnings and Revenue Estimates
06:26pm, Wednesday, 24'th Jan 2024
ResMed (RMD) came out with quarterly earnings of $1.88 per share, beating the Zacks Consensus Estimate of $1.81 per share. This compares to earnings of $1.66 per share a year ago.
ResMed beats estimates on strong sleep apnea device sales
06:07pm, Wednesday, 24'th Jan 2024
ResMed beat Wall Street estimates for second-quarter revenue and profit on Wednesday, powered by strong demand for its respiratory devices used to treat sleep apnea.
